Dr. Sheri Holmen on Brain Metastases in Melanoma
Sheri Holmen, PhD, discusses treating metastases in melanoma. Holmen says the treatment of metastases in melanoma is currently the cancer's biggest unmet clinical need, specifically brain metastases.
Sheri Holmen, PhD, associate professor, Department of Surgery, University of Utah School of Medicine, discusses treating metastases in melanoma. Holmen says the treatment of metastases in melanoma is currently the biggest unmet clinical need in melanoma, specifically brain metastases.
Holmen and her team of researchers came up with an in vivo model to examine the process of metastases and the biology behind why and how they occur. Holmen says the in vivo model is also useful in testing new therapies to either abate or cure the brain metastases.
Enasidenib Shows Promise as Post-Transplant Maintenance in IDH2-Mutated AML
January 7th 2025Amandeep Salhotra, MD, discussed the background and findings from a pilot trial evaluating enasidenib as post-hematopoietic stem cell transplant maintenance therapy for IDH2-mutated acute myeloid leukemia treatment.
Read More
